West Pharmaceutical Services, Inc. WST

370.44 (3.16) (0.85%) as of 25 Sep
Market cap
$26.3B
P/E
47.1×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years

West Pharmaceutical Services, Inc. (WST) P/B ratio

As of 25 September 2026, West Pharmaceutical Services, Inc. (WST) trades at a P/B ratio of 8.8×. Over the past ten years it has ranged from 3.6× (February 2015) to 17.1× (September 2021); the current reading is higher than 67% of that period. That is above the Medical Instruments & Supplies industry median of 2.8× and above the Healthcare sector median of 2.5×.

P/B ratio, daily

Annual

Period P/B ratio Change
FY2025 6.3× (29.74%)
FY2024 8.9× (0.87%)
FY2023 9.0× 38.44%
FY2022 6.5× (56.53%)
FY2021 14.9× 32.35%
FY2020 11.3× 59.66%
FY2019 7.1× 36.29%
FY2018 5.2× (9.69%)
FY2017 5.7× 4.18%
FY2016 5.5× 30.22%

Quarterly

Period P/B ratio Change
Jun 2026 8.5× 40.86%
Mar 2026 6.0× (3.65%)
Dec 2025 6.3× 0.91%
Sep 2025 6.2× 15.09%
42 more quarters

Against its own ten years

Low 3.6× High 17.1×
Ten-year median 6.9×
Current reading's percentile 67

P/B ratio against peers

Company P/B ratio
COO The Cooper Companies, Inc. compare 1.3×
ALC Alcon compare 1.5×
MDLN Medline Inc. compare 1.6×
BAX Baxter International Inc. compare 2.0×
BDX Becton, Dickinson and Company compare 2.1×
SOLV Solventum Corporation compare 3.2×
RMD ResMed Inc. compare 4.9×
RGEN Repligen Corporation compare 5.1×
WST West Pharmaceutical Services, Inc. 8.8×
Medical Instruments & Supplies industry median 2.8×
Healthcare sector median 2.5×
Market median 1.8×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on WST